Cargando…
+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
Background: Alterations of the insulin-like growth factor (IGF) pathway along with genetic variations of the IGF1 receptor (IGF1R) gene have been linked to the development of systemic autoimmunity, possibly through apoptosis induction. This study aims to investigate whether genetic variations of the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432056/ https://www.ncbi.nlm.nih.gov/pubmed/34501407 http://dx.doi.org/10.3390/jcm10173960 |
_version_ | 1783751075151478784 |
---|---|
author | Skarlis, Charalampos Marketos, Nikolaos Nezos, Adrianos Papanikolaou, Asimina Voulgarelis, Michael Koutsilieris, Michael Moutsopoulos, Haralampos M. Mavragani, Clio P. |
author_facet | Skarlis, Charalampos Marketos, Nikolaos Nezos, Adrianos Papanikolaou, Asimina Voulgarelis, Michael Koutsilieris, Michael Moutsopoulos, Haralampos M. Mavragani, Clio P. |
author_sort | Skarlis, Charalampos |
collection | PubMed |
description | Background: Alterations of the insulin-like growth factor (IGF) pathway along with genetic variations of the IGF1 receptor (IGF1R) gene have been linked to the development of systemic autoimmunity, possibly through apoptosis induction. This study aims to investigate whether genetic variations of the IGF1R contribute to Sjögren’s syndrome (SS) pathogenesis and explores potential functional implications. Methods: DNA extracted from whole peripheral blood derived from 277 primary SS patients, complicated or not by lymphoma, and 337 Healthy controls (HC) was genotyped for the rs2229765 IGF1R polymorphism using the RFLP-PCR assay. Gene expression of IGF1R and IGF1 isoforms, caspases 1, 4, and 5, and inflammasome components NLRP3, ASC, IL1β, IL18, IL33, IGFBP3, and IGFBP6 were quantitated by RT-PCR in total RNA extracted from minor salivary gland biopsies (MSGs) of 50 SS patients and 13 sicca controls (SCs). In addition, IGF1R immunohistochemical (IHC) expression was assessed in formalin-fixed, paraffin-embedded MSG tissue sections derived from 10 SS patients and 5 SCs. Results: The prevalence of the A/A genotype of the rs2229765 IGF1R polymorphism was significantly higher in the anti-Ro/SSA positive SS population compared to healthy controls (24.8% vs. 10.7%, p = 0.001). Moreover, IGF1Rs at both mRNA and protein levels were reduced in SS-derived MSGs compared to SCs and were negatively associated with caspase 1 transcripts. The latter were positively correlated with NLRP3, ASC, and IL1β at the salivary gland tissue level. IGF1R expression in peripheral blood was negatively correlated with ESR and IgG serum levels and positively correlated with urine-specific gravity values. Conclusions: The rs2229765 IGF1R variant confers increased susceptibility for seropositive primary SS. Dampened IGF1R mRNA and protein expression in salivary gland tissues could be related to increased apoptosis and subsequently to the activation of inflammasome pathways. |
format | Online Article Text |
id | pubmed-8432056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84320562021-09-11 +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications Skarlis, Charalampos Marketos, Nikolaos Nezos, Adrianos Papanikolaou, Asimina Voulgarelis, Michael Koutsilieris, Michael Moutsopoulos, Haralampos M. Mavragani, Clio P. J Clin Med Article Background: Alterations of the insulin-like growth factor (IGF) pathway along with genetic variations of the IGF1 receptor (IGF1R) gene have been linked to the development of systemic autoimmunity, possibly through apoptosis induction. This study aims to investigate whether genetic variations of the IGF1R contribute to Sjögren’s syndrome (SS) pathogenesis and explores potential functional implications. Methods: DNA extracted from whole peripheral blood derived from 277 primary SS patients, complicated or not by lymphoma, and 337 Healthy controls (HC) was genotyped for the rs2229765 IGF1R polymorphism using the RFLP-PCR assay. Gene expression of IGF1R and IGF1 isoforms, caspases 1, 4, and 5, and inflammasome components NLRP3, ASC, IL1β, IL18, IL33, IGFBP3, and IGFBP6 were quantitated by RT-PCR in total RNA extracted from minor salivary gland biopsies (MSGs) of 50 SS patients and 13 sicca controls (SCs). In addition, IGF1R immunohistochemical (IHC) expression was assessed in formalin-fixed, paraffin-embedded MSG tissue sections derived from 10 SS patients and 5 SCs. Results: The prevalence of the A/A genotype of the rs2229765 IGF1R polymorphism was significantly higher in the anti-Ro/SSA positive SS population compared to healthy controls (24.8% vs. 10.7%, p = 0.001). Moreover, IGF1Rs at both mRNA and protein levels were reduced in SS-derived MSGs compared to SCs and were negatively associated with caspase 1 transcripts. The latter were positively correlated with NLRP3, ASC, and IL1β at the salivary gland tissue level. IGF1R expression in peripheral blood was negatively correlated with ESR and IgG serum levels and positively correlated with urine-specific gravity values. Conclusions: The rs2229765 IGF1R variant confers increased susceptibility for seropositive primary SS. Dampened IGF1R mRNA and protein expression in salivary gland tissues could be related to increased apoptosis and subsequently to the activation of inflammasome pathways. MDPI 2021-08-31 /pmc/articles/PMC8432056/ /pubmed/34501407 http://dx.doi.org/10.3390/jcm10173960 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Skarlis, Charalampos Marketos, Nikolaos Nezos, Adrianos Papanikolaou, Asimina Voulgarelis, Michael Koutsilieris, Michael Moutsopoulos, Haralampos M. Mavragani, Clio P. +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title | +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title_full | +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title_fullStr | +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title_full_unstemmed | +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title_short | +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications |
title_sort | +3179g/a insulin-like growth factor-1 receptor polymorphism: a novel susceptibility contributor in anti-ro/ssa positive patients with sjögren’s syndrome: potential clinical and pathogenetic implications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432056/ https://www.ncbi.nlm.nih.gov/pubmed/34501407 http://dx.doi.org/10.3390/jcm10173960 |
work_keys_str_mv | AT skarlischaralampos 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT marketosnikolaos 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT nezosadrianos 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT papanikolaouasimina 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT voulgarelismichael 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT koutsilierismichael 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT moutsopoulosharalamposm 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications AT mavraganicliop 3179gainsulinlikegrowthfactor1receptorpolymorphismanovelsusceptibilitycontributorinantirossapositivepatientswithsjogrenssyndromepotentialclinicalandpathogeneticimplications |